Clinical Trials in Baltimore

Showing 4281-4300 of 17,176 trials

A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM

NCT02766699

The purpose of the Cerebral EDV study is to determine the safety and tolerability of EGFR(V)-EDV-Dox in order to establish the best dose level to be used in future studies. The study will also examine the body's immune response to EGFR(V)-EDV-Dox and assess if it is effective in the treatment of patients with recurrent glioblastoma multiforme (GBM).

GlioblastomaAstrocytoma, Grade IV

Engeneic Pty Limited9 participantsStarted Oct 2016

Baltimore, Maryland, United States • New York, New York, United States

COMPLETEDPhase 1< 1 mile

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

NCT06072157

This is a Phase 1, randomized, double-blind, placebo-controlled, sequential, single- and multiple-ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of intravenous (IV) infusions and a single subcutaneous (SC) injection of AK006. The study will be conducted in 4 parts: a single-ascending dose part (Part A) in healthy participants, a multiple-ascending dose part (Part B) in healthy participants with an expanded cohort (Part C) in participants with chronic spontaneous urticaria (CSU), and a single ascending dose SC injection cohort (Part D) in healthy participants.

Healthy ParticipantsChronic Spontaneous Urticaria

Allakos Inc.136 participantsStarted Aug 2023

Anniston, Alabama, United States • Birmingham, Alabama, United States • Scottsdale, Arizona, United States +22 more locations

A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

Find Trials by Condition in Baltimore

Surgical Treatments for Neuroma Pain in Amputees

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

MAGIC Ruxolitinib for aGVHD

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy